ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II-Reference-Cited by-同舟云学术

ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II

Published:2016-12 Issue:6 Volume:39 Page:535-544
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Dhakal Sughosh,Advani Ranjana,Ballas Leslie K.,Dabaja Bouthaina S.,Flowers Christopher R.,Ha Chul S.,Hoppe Bradford S.,Mendenhall Nancy P.,Metzger Monika L.,Plastaras John P.,Roberts Kenneth B.,Shapiro Ronald,Smith Sonali M.,Terezakis Stephanie A.,Winkfield Karen M.,Younes Anas,Constine Louis S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference66 articles.

1. The EORTC trials for limited stage Hodgkin’s disease. The EORTC Lymphoma Cooperative Group;Cosset;Eur J Cancer,1992

2. Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin’s disease. The EORTC Lymphoma Group controlled clinical trials: 1964–1987;Tubiana;Blood,1989

3. Extended mantle radiation therapy for pathologic stage I and II Hodgkin’s disease;Farah;J Clin Oncol,1988

4. The management of stage I–II Hodgkin’s disease with irradiation alone or combined modality therapy: the Stanford experience;Hoppe;Blood,1982

5. Stage IA and IIA supradiaphragmatic Hodgkin’s disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation;Mauch;J Clin Oncol,1988

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of cognitive–behavioural play therapy and puppet play therapy on bilingual children’s expressive, receptive language disorders;Early Child Development and Care;2024-01-25

2. Controversies in the Approach to Initial Therapy of Hodgkin Lymphoma;Current Oncology Reports;2019-03-27

3. ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II: Erratum;American Journal of Clinical Oncology;2017-02

4. Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors;Clinical Medicine Insights: Oncology;2017-01-01